Status:

COMPLETED

Colchicine in Moderate Symptomatic COVID-19 Patients

Lead Sponsor:

Dhaka Medical College

Conditions:

Covid19

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a prospective, double blind, randomized, placebo controlled clinical trial. The participants will be randomized into two groups (group A and group B). Patients of group-A are the treatment gro...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • Males and females of least 18 years of age and can swallow tablets
  • Competent and willing to provide informed consent
  • Patient must have received a diagnosis of COVID-19 infection with positive RT-PCR for SARS CoV-2 within the last 3 days
  • Patients with moderate symptoms (According to National Guidelines on Clinical Management of Coronavirus Disease 2019 (COVID- 19).Version 7.0 .2020, DGHS, MOHFW, Government of the People's Republic of Bangladesh). Following features of moderate covid-19 must be present-
  • Fever or history of fever
  • Cough and /or Shortness of breath
  • Oxygen saturation 94% or more
  • Pneumonia -pulmonary consolidations on chest imaging (chest x ray or CT scan of chest) involving less than 50%of lungs
  • CRB 65 score 0
  • Exclusion criteria:
  • Pregnancy and breast-feeding
  • Known hypersensitivity to colchicine
  • Known chronic illness e.g hepatic failure, chronic kidney disease (eGFR\<30ml/min), decompensated heart failure, long QT syndrome (QTc \>450 msec.)
  • Patient with inflammatory bowel disease (Crohn's disease or ulcerative colitis), chronic diarrhea or malabsorption
  • Patient currently taking colchicine for other indications (mainly chronic indications represented by Familial Mediterranean Fever or gout)
  • Patient undergoing chemotherapy for cancer
  • Patient is considered by the investigator, for any reason, to be an unsuitable candidate for the study.

Exclusion

    Key Trial Info

    Start Date :

    July 14 2020

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    December 10 2020

    Estimated Enrollment :

    299 Patients enrolled

    Trial Details

    Trial ID

    NCT04527562

    Start Date

    July 14 2020

    End Date

    December 10 2020

    Last Update

    January 11 2021

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Dhaka Medical College Hospital

    Dhaka-1000, Bangladesh